Bioactive by-products
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-02334 |
Pacidamycin 2 (121264-06-0) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02335 |
Pacidamycin 3 (121280-49-7) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02336 |
Pacidamycin 5 (122855-43-0) Inquiry |
|
It is produced by the strain of Str. coeruleorubidus AB 1183F-64. It has inhibitory effect on Pseudomonas aeruginosa. It also has effect on a few strains of bacteria such as suppurative staphylococcus and Escherichia coli. Serum can reduce its antibacterial activity, pH also affects its antibacterial activity. |
||
BBF-02362 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02363 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02364 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. |
||
BBF-02365 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02366 | ||
It is produced by the strain of Lachnum papyraceum. It has weak effect against nematodes and has inhibitory effect on L1210 and HL60 cells. It also has weak anti-gram-positive bacterial effect. |
||
BBF-02418 |
Piloquinone (25414-26-0) Inquiry |
|
It is produced by the strain of Str. pilosus. It's a phenanthrene compound. It has inhibitory effect on mycobacterium and protozoa, but the effect is not strong. |
||
BBF-02428 | ||
Sch 50673 is an antitumor metabolite produced by Nattrassia mangiferae. |
||
BBF-02429 | ||
Sch 50676 is an antitumor metabolite produced by Nattrassia mangiferae. |
||
BBF-02430 | ||
Sch 52900 is an inhibitor of c-fos proto-oncogene induction, which is isolated from the fermentation of broth of the fungal culture (SCF-1168), Gliocladium sp. |
||
BBF-02431 | ||
Sch 52901 is an inhibitor of c-fos proto-oncogene induction, which is isolated from the fermentation of broth of the fungal culture (SCF-1168), Gliocladium sp. |
||
BBF-02432 | ||
Sch 56396 is a c-fos proto-oncogene inhibitor produced by the fungus Tolypocladium sp. |
||
BBF-02434 | ||
Sch 218157 is a cyclodepsipeptide isolated from an unidentified fungus MYCO-2833. It selectively binds to NK2 receptor with IC50 of 68 nmol/L. |
||
BBF-02437 | ||
Sch 466457 is a peptide active against Candida, dermatophytes and Aspergillus with MIC of 8.9, 20 and 16 microg/mL. |
||
BBF-02442 | ||
Sch 599473 is a sesterterpene isolated from from a marine sponge, Ircinia sp. It inhibits CCR7 receptor with IC50 of 33 μg/mL. |
||
BBF-02465 | ||
SMTP-1 is a Staplabin homolog isolated from Stachybotrys microspora IFO30018. It enhanced the binding of Plasminogen to Fibrin. |
||
BBF-02466 | ||
SMTP-2 is a Staplabin homolog isolated from Stachybotrys microspora IFO30018. It enhanced the binding of Plasminogen to Fibrin. The activity of SMTP-2 is weaker than SMTP-1. |
||
BBF-02467 | ||
SMTP-3 is a Staplabin homolog isolated from Stachybotrys microspora IFO30018. It enhanced the binding of Plasminogen to Fibrin. |